Intarcia Therapeutics

Closed

Unlocking life's possibilities

San Francisco, United States · Founded 1997 · $210.0M raised

Headquarters
San Francisco
Employees
201–500
Founded
1997
Business Model
Other
Total Funding
$210.0M
Last Round
$210.0M Venture RoundNov 2012
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Intarcia Therapeutics, Inc. is a rapidly emerging biotech company committed to redesigning the treatment, prevention, and experience of chronic disease. The company operates with a 'No Analog' mindset, pushing boundaries with cross-disciplinary teams of scientists and entrepreneurs. Founded in 1997, it previously focused on implantable drug delivery devices and has raised significant funding.

Summary

Intarcia Therapeutics is a Drug Discovery company based in San Francisco, United States, founded in 1997. It has raised $210.0M in total across 1 round, most recently a $210.0M Venture Round in Nov 2012. Investors include MidCap Financial and Silicon Valley Bank.

Tech & App Stack

10 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Debt FinancingDebt FinancingMay 2016
$75.0M

Sign up to see all 2 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Shields Health Solutions

The nation's first company to integrate specialty pharmacies into hospitals and health systems, h...

United StatesHealthcare, Drug Discovery
Corporate RoundTotal funding$3.5BSep 2025
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Enveda

Enveda reads and translates nature’s hidden chemistry to accelerate the discovery of better medic...

Boulder, United States201–500Biotech, Artificial Intelligence
Series ETotal funding$1.1BSep 2026
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Intarcia Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/intarcia-therapeutics"><img src="https://indexed.vc/api/badge/company/intarcia-therapeutics" alt="Intarcia Therapeutics on Indexed.vc" width="260" height="76" /></a>